Effect of urantide on myocardial apoptosis in rats induced by ischemia/reperfusion injury

Chinese Journal of Pharmacology and Toxicology

Volumn 25, Issue 2, 2011, Pages 127-134

  Yao, Hua ^a   Zhang, Jun Yan ^a   Chen, Zhi Wu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Myocardial; Reperfusion injury; Urantide

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; URANTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; REOXYGENATION; REPERFUSION INJURY;

RATTUS;

EID: 79955849339     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: 10.3867/j.issn.1000-3002.2011.02.001     Document Type: Article

References (22)

1. Bern HA, Lederis K. A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts[J]. / Endocrinol, 1969, 45(Suppl 1) : XI-XII.
2. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, et al. Human urotensin- II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J]. Nature, 1999, 401 (6750) : 282-286.
3. Douglas SA, Ohlstein EH. Hman urotesin H, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease [ J ]. Trends Cardiovasc Med, 2000, 10 (6): 229-237. (Pubitemid 32229878)
4. Tran L, Kompa AR, Kemp W, Phrommintikul A, Wang BH, Krum H. Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats[J]. Am J Physiol Heart Circ Physiol, 2010, 298(2) : H608-H613.
5. Chen YH, Yandle TG, Richards AM, Palmer SC. Urotensin II immunoreactivity in the human circulation; evidence for widespread tissue release[J]. Clin Chem, 2009, 55(11): 2040-2048.
6. Patacchini R, Santicioli P, Giuliani S, Grieco P, Novellino E, Rovero P, et al. Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta[ J]. Br J Pharmacol, 2003, 140(7) : 1155-1158. (Pubitemid 38117417)
7. Camarda V, Guerrini R, Kostenis E, Rizzi A, Calò G, Hattenberger A, et al. A new ligand for the urotensin Il receptor[J]. Br J Pharmacol, 2002, 137(3): 311-314.
8. Shi Y, Cao YX, Lu N, Yao T, Zhu YC. Hemodynamic-independent anti - natriuretic effect of urotensin H in spontaneously hypertensive rats [J]. Peptides, 2008, 29(5) : 783-794.
9. Kemp W, Kompa A, Phrommintikul A, Herath C, Zhiyuan J, Angus P, et al. Urotensin H modulates hepatic fibrosis and portal hemodynamic alterations in rats [J]. Am J Physiol Gastrointest Liver Physiol, 2009, 297(4) G762-G767.
10. Abdel-Razik AE, Balment RJ, Ashton N. Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II [J]. Am J Physiol Renal Physiol, 2008, 295(4) : F1239-F1247.
11. Wang TL, Chang H, Hung CR, Tseng YZ. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction [J]. Cardiovasc Res, 1998, 40(3) : 557-563. (Pubitemid 28557297)
12. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis[ J]. J Neurosa, 1997, 17(13) : 5089-5100.
13. Telford WG, King LE, Fraker PJ. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry [ J ]. Cell Prolif, 1991, 24 (5) : 447-459.
14. Maulik N, Sasaki H, Galang N. Differential regulation of apoptosis by ischemia - reperfusion and ischemic adaptation [ J ]. Ann N Y Acad Sci, 1999, 874:401-411. (Pubitemid 29351960)
15. Li Q, Li Z, Mei Y, Guo Y. Neuregulin attenuated cerebral ischemia-Creperfusion injury via inhibiting apoptosis and upregulating aquaporin-4 [J]. Neurosci Lett, 2008, 443(3) : 155-159.
16. Skommer J, Wlodkowic D, Deptala A. Larger than life: mitochondria and the Bcl-2 family [J]. Leuk Res, 2007, 31(3) : 277-286. (Pubitemid 46073182)
17. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2 [J]. Am J Physiol Cell Physiol, 2008, 294(6) : C1509-C1520.
18. Zhao ZQ, Budde JM, Morris C, Wang NP, Velez DA, Muraki S, et al. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins[ J]. J Mol Cell Cardiol, 2001, 33(1): 57-68. (Pubitemid 32127784)
19. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P. Tanshinone II A protects cardiac myocytes against oxidative stress-triggered damage and apoptosis [ J]. Eur J Pharmacol, 2007, 568(1-3): 213-221. (Pubitemid 46976900)
20. Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, et al. Urotensin- II -mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators [J]. Naunyn Schmiedebergs Arch Pharmacol, 2004, 370(4) : 238-250. (Pubitemid 40063823)
21. Shi LB, Ding W, Li D, Wang Z, Jiang H, Zhang J, et al. Proliferation and anti - apoptotic effects of human urotensin II on human endothelial cells [J]. Atherosclerosis, 2006, 188(2): 260-264. (Pubitemid 44313921)